JY
TBRA

Jeff Yass’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Jeff Yass’s Portfolio TBRA Stock Details TBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-20,100
Closed -$799K – 10609
2016
Q3 		$799K Buy
+20,100
New +$224K ﹤0.01% 5211

Jeff Yass's TBRA Position: Q4 2016 in Review

Jeff Yass sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 159,374 shares — an estimated $6.33M sold.

Jeff Yass first reported a position in TBRA in Q1 2014 and held it in 4 quarters. The position peaked at $6.33M in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

  • Jeff Yass reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • Jeff Yass sold 159,374 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $6.33M.
  • Jeff Yass first reported a position in Tobira Therapeutics, Inc. Common Stock in Q1 2014 and held it in 4 quarters.
  • Jeff Yass's Tobira Therapeutics, Inc. Common Stock position peaked at $6.33M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Susquehanna International Group's 13F filing for Q4 2016, filed 14 Feb 2017.